Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Williams, H. J. Articles by O’Donovan, M. C. Search for Related Content PubMed Citation Articles by Williams, H. J. Articles by O’Donovan, M. C. Schizophrenia Spectrum Disorders Genetics

No Association Between Schizophrenia and Polymorphisms in COMT in Two Large Samples

OBJECTIVE: A valine/methionine polymorphism in the catechol O-methyltransferase (COMT) gene has been proposed to influence susceptibility to schizophrenia, as has a COMT haplotype in Ashkenazi Jewish and Irish subjects. The authors examined these hypotheses. METHOD: They reviewed data from more than 2,800 individuals, including almost 1,200 with schizophrenia, from case-control and family-based European association samples. RESULTS: The authors found no support for the hypothesis that a valine/methionine polymorphism in the COMT gene influences susceptibility to schizophrenia or the hypothesis that a COMT haplotype influences susceptibility to schizophrenia in Ashkenazi Jewish and Irish subjects. CONCLUSIONS: The data suggest that the valine allele of COMT does not increase susceptibility to schizophrenia in Europeans and that the Ashkenazi or Irish haplotype does not increase susceptibility. Ethnic variation in the linkage disequilibrium structure at COMT means that the haplotype data may not generalize across populations. However, the authors’ examination of the hypothesis that the valine allele confers susceptibility, with a particularly strong effect in Europeans, reveals that no such caveat applies.

This article has been cited by other articles:

				M. E. Talkowski, G. Kirov, M. Bamne, L. Georgieva, G. Torres, H. Mansour, K. V. Chowdari, V. Milanova, J. Wood, L. McClain, et al. A network of dopaminergic gene variations implicated as risk factors for schizophrenia Hum. Mol. Genet., March 1, 2008; 17(5): 747 - 758. [Abstract] [Full Text] [PDF]

				S. ZAMMIT, G. SPURLOCK, H. WILLIAMS, N. NORTON, N. WILLIAMS, M. C. O'DONOVAN, and M. J. OWEN Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use The British Journal of Psychiatry, November 1, 2007; 191(5): 402 - 407. [Abstract] [Full Text] [PDF]

				M. E. Talkowski, M. Bamne, H. Mansour, and V. L. Nimgaonkar Dopamine Genes and Schizophrenia: Case Closed or Evidence Pending? Schizophr Bull, September 1, 2007; 33(5): 1071 - 1081. [Abstract] [Full Text] [PDF]

				H. J. Williams, M. J. Owen, and M. C. O'Donovan Is COMT a Susceptibility Gene for Schizophrenia? Schizophr Bull, May 1, 2007; 33(3): 635 - 641. [Abstract] [Full Text] [PDF]

				D. L. Braff, R. Freedman, N. J. Schork, and I. I. Gottesman Deconstructing Schizophrenia: An Overview of the Use of Endophenotypes in Order to Understand a Complex Disorder Schizophr Bull, January 1, 2007; 33(1): 21 - 32. [Abstract] [Full Text] [PDF]

				H. M. Abdolmaleky, K.-h. Cheng, S. V. Faraone, M. Wilcox, S. J. Glatt, F. Gao, C. L. Smith, R. Shafa, B. Aeali, J. Carnevale, et al. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder Hum. Mol. Genet., November 1, 2006; 15(21): 3132 - 3145. [Abstract] [Full Text] [PDF]

				L. Georgieva, V. Moskvina, T. Peirce, N. Norton, N. J. Bray, L. Jones, P. Holmans, S. MacGregor, S. Zammit, J. Wilkinson, et al. Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia PNAS, August 15, 2006; 103(33): 12469 - 12474. [Abstract] [Full Text] [PDF]

				J. A. Gogos and D. J. Gerber Schizophrenia Susceptibility Genes: Emergence of Positional Candidates and Future Directions Focus, August 1, 2006; 4(3): 369. [Abstract] [Full Text] [PDF]

				N. M. Williams, E. K. Green, S. Macgregor, S. Dwyer, N. Norton, H. Williams, R. Raybould, D. Grozeva, M. Hamshere, S. Zammit, et al. Variation at the DAOA/G30 Locus Influences Susceptibility to Major Mood Episodes but Not Psychosis in Schizophrenia and Bipolar Disorder. Arch Gen Psychiatry, April 1, 2006; 63(4): 366 - 373. [Abstract] [Full Text] [PDF]

				N. Craddock, M. C O'Donovan, and M. J Owen Genes for Schizophrenia and Bipolar Disorder? Implications for Psychiatric Nosology Schizophr Bull, January 1, 2006; 32(1): 9 - 16. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2005 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us